Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

ITRM

ITRM News

Newswire

10:47

Iterum Therapeutics shares rise 14.63% intraday after FDA clears sulopenem test disc and ORLYNVAH stocked at McKesson.

10:07

Iterum Therapeutics shares surge 10.81% intraday after director Dunne buys $2,191 in shares.

07:08

Iterum Therapeutics Director Dunne Buys 6,000 Shares at $0.37/Share on 11/18/2025.

06:34

Iterum Therapeutics shares surge 10.44% premarket after launching ORLYNVAH™, the first oral penem antibiotic in the U.S.

16:10

Iterum Therapeutics Posts Q3 2025 Earnings: Launch Success and Financial Challenges

View More

About ITRM

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More